Share

    


In This Section

Home / Learn / Cancer Types / Breast Cancer / Breast Cancer Project Advisory Committees

Breast Cancer Project Advisory Committees

Addressing Challenges in Oral Therapies for HR+, HER2- Breast Cancer

Kelly Gast
Kelly C. Gast, MD
Medical Oncologist, Breast Medical Oncology
Saint Luke’s Cancer Institute at Saint Luke’s Health System
Kansas City, MO

Kelly Gast, MD is a breast medical oncologist practicing at Saint Luke’s Cancer Institute in Kansas City, Missouri. Her clinical and research interests include cancer survivorship, symptom control, and management of treatment associated toxicities.

Dr Gast completed fellowship training in hematology and medical oncology at The Ohio State University Comprehensive Cancer Center and internal medicine residency at Mayo Clinic in Rochester, Minnesota.

Eliminating Disparities in Access to Quality Cancer Care in African American Women with Triple Negative Breast Cancer

Kelly Gast
Kelly C. Gast, MD
Medical Oncologist, Breast Medical Oncology
Saint Luke’s Cancer Institute at Saint Luke’s Health System
Kansas City, MO

Kelly Gast, MD is a breast medical oncologist practicing at Saint Luke’s Cancer Institute in Kansas City, Missouri. Her clinical and research interests include cancer survivorship, symptom control, and management of treatment associated toxicities.

Dr Gast completed fellowship training in hematology and medical oncology at The Ohio State University Comprehensive Cancer Center and internal medicine residency at Mayo Clinic in Rochester, Minnesota.

Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

Kelly Gast
Kelly C. Gast, MD
Medical Oncologist, Breast Medical Oncology
Saint Luke’s Cancer Institute at Saint Luke’s Health System
Kansas City, MO

Kelly Gast, MD is a breast medical oncologist practicing at Saint Luke’s Cancer Institute in Kansas City, Missouri. Her clinical and research interests include cancer survivorship, symptom control, and management of treatment associated toxicities.

Dr Gast completed fellowship training in hematology and medical oncology at The Ohio State University Comprehensive Cancer Center and internal medicine residency at Mayo Clinic in Rochester, Minnesota.

Quality Improvement in Breast Cancer Through BRCA Testing

Kelly Gast
Kelly C. Gast, MD
Medical Oncologist, Breast Medical Oncology
Saint Luke’s Cancer Institute at Saint Luke’s Health System
Kansas City, MO

Kelly Gast, MD is a breast medical oncologist practicing at Saint Luke’s Cancer Institute in Kansas City, Missouri. Her clinical and research interests include cancer survivorship, symptom control, and management of treatment associated toxicities.

Dr Gast completed fellowship training in hematology and medical oncology at The Ohio State University Comprehensive Cancer Center and internal medicine residency at Mayo Clinic in Rochester, Minnesota.

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams: 2023 BRCA Testing Reassessment Survey

Kelly Gast
Kelly C. Gast, MD
Medical Oncologist, Breast Medical Oncology
Saint Luke’s Cancer Institute at Saint Luke’s Health System
Kansas City, MO

Kelly Gast, MD is a breast medical oncologist practicing at Saint Luke’s Cancer Institute in Kansas City, Missouri. Her clinical and research interests include cancer survivorship, symptom control, and management of treatment associated toxicities.

Dr Gast completed fellowship training in hematology and medical oncology at The Ohio State University Comprehensive Cancer Center and internal medicine residency at Mayo Clinic in Rochester, Minnesota.